Advertisement

Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever

  • Rabia Miray Kisla EkinciEmail author
  • Sibel Balcı
  • Eray Akay
  • Gokhan Tumgor
  • Dilek Dogruel
  • Derya Ufuk Altintas
  • Mustafa Yilmaz
Original Article
  • 27 Downloads

Abstract

Introduction

Familial Mediterranean fever (FMF) is characterized by self-limiting fever episodes usually accompanied by serositis, arthralgia, and arthritis. Functional gastrointestinal disorders (FGIDs) are diseases in which brain-gut axis and low-grade inflammation take part in pathogenesis. We aimed to study the FGIDs frequencies and possible risk factors for FGIDs in children with FMF.

Method

This case-control study included 103 children with FMF followed up between July 2016 and July 2018 and 100 healthy controls. Age, gender, disease characteristics, and MEFV gene results were recorded retrospectively. Laboratory parameters were obtained at the time of study enrollment. Diagnosis of FGIDs was assessed with Rome IV criteria.

Results

The mean age at study enrollment was 12.58 ± 3.79 and 9.71 ± 3.59 years in FMF and healthy control groups, respectively. Overall FGID frequency was 39.8% (n = 41) in FMF patients and 19% (n = 19) in the control group. Functional dyspepsia and irritable bowel syndrome (particularly constipation predominant subtype) rates were statistically higher in the FMF group. In detail, genotype, age at onset, symptoms, colchicine duration, and colchicine responses did not differ between FMF patients in regard to having FGIDs.

Conclusions

This study showed that children with FMF may predispose to pain predominant FGIDs. We also suggest that FGIDs should be considered in FMF patients suffering recurrent abdominal pain episodes unaccompanied by APR elevation, which can be also named as incomplete FMF attacks.

Keywords

Familial Mediterranean fever Functional dyspepsia Functional gastrointestinal disorders Irritable bowel syndrome Rome IV 

Notes

Compliance with ethical standards

Informed consents were obtained from the parents of the patients prior to the study enrollment. The study was approved by Ethics committee of our Medical Faculty.

Disclosures

None.

References

  1. 1.
    Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664CrossRefGoogle Scholar
  2. 2.
    Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921CrossRefGoogle Scholar
  3. 3.
    de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–874CrossRefGoogle Scholar
  4. 4.
    Ozen S, Demirkaya E, Erer, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651CrossRefGoogle Scholar
  5. 5.
    Koloski NA, Talley NJ, Boyce PM (2002) Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 97:2290–2299CrossRefGoogle Scholar
  6. 6.
    Keely S, Walker MM, Marks E, Talley NJ (2015) Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Investig 45:1350–1359CrossRefGoogle Scholar
  7. 7.
    Kisla Ekinci RM, Balci S, Mart OO, Tumgor G, Yavuz S, Celik H, Dogruel D, Altintas DU, Yilmaz M (2018 published on 12 August 2018) Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children? Rheumatol Int.  https://doi.org/10.1007/s00296-018-4129-7
  8. 8.
    Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA (2018) Functional abdominal pain disorders in children. Expert Rev Gastroenterol Hepatol 12:369–390CrossRefGoogle Scholar
  9. 9.
    Hyams JS, Di Lorenzo C, Saps M, Perera BJC, Benninga MA (2016) Functional disorders: children and adolescents. Gastroenterology 150 e2:1456–1468CrossRefGoogle Scholar
  10. 10.
    Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O (2018) Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 38:67–74CrossRefGoogle Scholar
  11. 11.
    Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRefGoogle Scholar
  12. 12.
    Mor A, Gal R, Livneh A (2003) Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol 98:2594–2604CrossRefGoogle Scholar
  13. 13.
    Asakura K, Yanai S, Nakamura S, Kawaski K, Eizuka M, Ishida K, Endo M, Sugai T, Migita K, Matsumoto T (2018) Familial Mediterranean fever mimicking Crohn disease: a case report. Medicine (Baltimore) 97:e9547CrossRefGoogle Scholar
  14. 14.
    Güncan S, Bilge NŞ, Cansu DÜ, Kaşifoğlu T, Korkmaz C (2016) The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever. Eur J Rheumatol 3:118–121CrossRefGoogle Scholar
  15. 15.
    Özçakar ZB, Çakar N, Uncu N, Çelikel BA, Yalçinkaya F (2017) Familial Mediterranean fever-associated diseases in children. QJM 110:287–290Google Scholar
  16. 16.
    Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A (2002) Crohn disease in patients with familial Mediterranean fever. Medicine 81:411–416CrossRefGoogle Scholar
  17. 17.
    Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grütter C, Grütter M, Tschopp J (2007) The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14:1457–1466CrossRefGoogle Scholar
  18. 18.
    Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L, McCormick M, Zhang Z, Alnemri ES (2007) Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 28:214–227CrossRefGoogle Scholar
  19. 19.
    Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL (2011) Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 34:755–768CrossRefGoogle Scholar
  20. 20.
    Tanaka Y, Kanazawa M, Fukudo S, Drossman DA (2011) Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil 17:131–139CrossRefGoogle Scholar
  21. 21.
    Farmer AD, Aziz Q (2014) Mechanisms of visceral pain in health and functional gastrointestinal disorders. Scand J Pain 5:51–60CrossRefGoogle Scholar
  22. 22.
    Brik R, Litmanovich D, Berkowitz D, Shamir R, Rosenthal E, Shinawi M, Gershoni-Baruch R (2001) Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr 138:759–762CrossRefGoogle Scholar
  23. 23.
    Börekci E, Celikbilek M, Soytürk M, Akar S, Börekci H, Günaydin I (2017) Functional gastrointestinal disorders in patients with familial Mediterranean fever. Int J Rheum Dis 20:2101–2105CrossRefGoogle Scholar
  24. 24.
    Kucuk A, Biyik M, Solak Y, Ucar R, Polat I, Pektas F, Gungor G, Gaipov A, Bagcaci S, Ataseven H, Tunc R (2015) Irritable bowel syndrome prevalence in patients with familial Mediterranean fever. Acta Medica Mediterranea 31:841–846Google Scholar
  25. 25.
    Ozçakar ZB, Yalçinkaya F, Yüksel S, Acar B, Gökmen D, Ekim M (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25(2):149–152CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Department of Pediatric RheumatologyCukurova University Faculty of MedicineAdanaTurkey
  2. 2.Department of PediatricsCukurova University Faculty of MedicineAdanaTurkey
  3. 3.Department of Pediatric GastroenterologyCukurova University Faculty of MedicineAdanaTurkey
  4. 4.Department of Pediatric Allergy and ImmunologyCukurova University Faculty of MedicineAdanaTurkey

Personalised recommendations